March 2016
Features
Vitrectomy Platforms Go To The Next Level
EVA has raised the bar on cut rate and vacuum and flow vitrectomy modes, but others have made upgrades, too.
Noninfectious Uveitis: Enriching Our Toolbox
Recent advances in localized therapies provide options to traditional systemic immunosuppression.
How Will DRCR.net Protocol S Change Our Practice?
Giving us clarity on the use of PRP and anti-VEGF in high-risk PDR.
HORV: A Rare But Devastating Complication of Endophthalmitis Prophylaxis
Hemorrhagic occlusive retinal vasculitis has been associated with routine intracameral vancomycin use.
Pediatric Retina: Advances in Diagnosis and Treatment
Widefield imaging, anti-VEGF agents and shorter instruments expand management options.
Full-Thickness Retino-choroidal Biopsy: Reaching Into Your VR Bag of Tricks
Small-gauge instruments may make this procedure more feasible for vitreoretinal surgeons.
Departments
Coding Commentary
Coding and Reimbursement Updates
Changes in 2016 amount to a sharp reduction in physician reimbursements.
Editor's Page
Innovation Insight
An App to Monitor Patients At Home
Mobile system can alert retina specialists to vision changes before patients can.
Medical Retina Fellows Forum
Subclinical MNV: Do We Watch or Treat?
Now that we have OCT-A, we can no longer ignore macular neovascularization in non-exudative AMD.
News
Retina CEO
The Case for Certified Personnel
Reimbursement and regulatory challenges demand certified staff.
Retina Rounds
Trouble With a Treated Tumor
The source of a scotoma came down to components of both differential diagnoses.
Surgical Pearl Video
Preventing Folds After RD Repair
Temporal side down: because face-down positioning isn’t foolproof or fold-proof.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
